Shanghai Pulmonary Hospital, Shanghai, China clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Toripalimab and JS004 Combined With Platinum-based Chemotherapy…Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

   Completed without a posted recruiting period

   Also in this update: Primary completion date changed from estimate of Sep 1, 2030 to Aug 29, 2026

   Shanghai Pulmonary Hospital, Shanghai, China·Phase 2· NCT06648200· Registry history of NCT06648200 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

2. Minor

   Impact of Communication With Healthcare Providers Via WeChat on…Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns

   Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting

   Shanghai Pulmonary Hospital, Shanghai, China·Not specified· NCT06592430· Registry history of NCT06592430 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.